首页 > 最新文献

Journal of global antimicrobial resistance最新文献

英文 中文
Pseudomonas aeruginosa epidemic high-risk clones and their association with multidrug-resistant 铜绿假单胞菌流行病高危克隆及其与耐多药菌的关系
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-15 DOI: 10.1016/j.jgar.2024.07.003

Objective

In Ecuador, data on molecular epidemiology, as well as circulating clones, are limited. Therefore, this study aims to know the population structure of Pseudomonas aeruginosa by identifying clones in clinical samples in Quito-Ecuador.

Methods

A significant set (45) clinical P. aeruginosa isolates were selected, including multidrug and non-multidrug resistant isolates, which were assigned to sequence types (STs) and compared with their antibiotic susceptibility profile. The genetic diversity was assessed by applying the multilocus sequence typing (MLST) scheme and the genetic relationships between different STs were corroborated by phylogenetic networks.

Results

The MLST analysis identified 24 different STs and the most prevalent STs were ST-3750 and ST-253. The majority of the multidrug-resistance (MDR) isolates were included in ST-3750 and ST-253, also 3 singleton STs were identified as MDR isolates. The 21 different STs were found in non-multidrug resistance (non-MDR) isolates, and only 3 STs were found in more the one isolate.

Conclusions

The population structure of clinical P. aeruginosa present in these isolates indicates a significant association between MDR isolates and the clonal types: all ST-3750 and ST-253 isolates were MDR. ST-3750 is a closely related strain to the clonal complex ST111 (CC111). ST-253 and ST111 are a group of successful high-risk clones widely distributed worldwide. The multiresistant isolates studied are grouped in the most prevalent STs found, and the susceptible isolates correspond mainly with singleton STs. Therefore, these high-risk clones and their association with MDR phenotypes are contributing to the spread of MDR in Quito, Ecuador.

背景:在厄瓜多尔,有关分子流行病学以及循环克隆的数据十分有限。因此,本研究旨在通过鉴定厄瓜多尔基多省临床样本中的克隆,了解铜绿假单胞菌的种群结构:方法:选取了大量临床铜绿假单胞菌分离株(45 株),包括耐多药和非耐多药分离株,将其归入序列类型(ST),并与其抗生素敏感性谱进行比较。应用多焦点序列分型(MLST)方案评估了遗传多样性,并通过系统发育网络证实了不同 ST 之间的遗传关系:结果:MLST分析确定了24种不同的ST,最常见的ST是ST-3750和ST-253。大多数耐多药(MDR)分离株都属于 ST-3750 和 ST-253,还有 3 个单株 ST 被鉴定为 MDR 分离株。在非多重耐药性(非 MDR)分离株中发现了 21 种不同的 ST,只有 3 种 ST 在多个分离株中发现:结论:这些分离物中存在的临床铜绿假单胞菌的种群结构表明,多重耐药分离物与克隆类型之间存在显著关联:所有 ST-3750 和 ST-253 分离物均为多重耐药分离物。ST-3750 是与克隆复合体 ST111(CC111)密切相关的菌株。ST-253 和 ST111 是一组成功的高风险克隆,广泛分布于世界各地。所研究的多重耐药分离株按发现的最普遍序列类型分组,而易感分离株主要对应单序列类型。因此,这些高风险克隆及其与多重耐药性表型的关联正在助长多重耐药性在厄瓜多尔基多的蔓延。
{"title":"Pseudomonas aeruginosa epidemic high-risk clones and their association with multidrug-resistant","authors":"","doi":"10.1016/j.jgar.2024.07.003","DOIUrl":"10.1016/j.jgar.2024.07.003","url":null,"abstract":"<div><h3>Objective</h3><p>In Ecuador, data on molecular epidemiology, as well as circulating clones, are limited. Therefore, this study aims to know the population structure of <em>Pseudomonas aeruginosa</em> by identifying clones in clinical samples in Quito-Ecuador.</p></div><div><h3>Methods</h3><p>A significant set (45) clinical <em>P. aeruginosa</em> isolates were selected, including multidrug and non-multidrug resistant isolates, which were assigned to sequence types (STs) and compared with their antibiotic susceptibility profile. The genetic diversity was assessed by applying the multilocus sequence typing (MLST) scheme and the genetic relationships between different STs were corroborated by phylogenetic networks.</p></div><div><h3>Results</h3><p>The MLST analysis identified 24 different STs and the most prevalent STs were ST-3750 and ST-253. The majority of the multidrug-resistance (MDR) isolates were included in ST-3750 and ST-253, also 3 singleton STs were identified as MDR isolates. The 21 different STs were found in non-multidrug resistance (non-MDR) isolates, and only 3 STs were found in more the one isolate.</p></div><div><h3>Conclusions</h3><p>The population structure of clinical <em>P. aeruginosa</em> present in these isolates indicates a significant association between MDR isolates and the clonal types: all ST-3750 and ST-253 isolates were MDR. ST-3750 is a closely related strain to the clonal complex ST111 (CC111). ST-253 and ST111 are a group of successful high-risk clones widely distributed worldwide. The multiresistant isolates studied are grouped in the most prevalent STs found, and the susceptible isolates correspond mainly with singleton STs. Therefore, these high-risk clones and their association with MDR phenotypes are contributing to the spread of MDR in Quito, Ecuador.</p></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213716524001309/pdfft?md5=3b58ad5e6062fb8d5645e15ef495d76b&pid=1-s2.0-S2213716524001309-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141633739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and characterization of an integrative and conjugative element carrying tet(X) gene in Elizabethkingia meningoseptica 携带 tet(X) 基因的伊丽莎白金色姬蛙的整合和共轭元素的流行与特征。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-14 DOI: 10.1016/j.jgar.2024.07.001

Objectives

To investigate the tet(X) gene, a determinant of tigecycline resistance, in the emerging pathogen Elizabethkingia meningoseptica and its association with an integrative and conjugative element (ICE).

Methods

All E. meningoseptica genomes from the National Center for Biotechnology Information (n = 87) were retrieved and annotated for resistome searches using the CARD database. A phylogenic analysis was performed based on the E. meningoseptica core genome. The ICE was identified through comparative genomics with other ICEs occurring in Elizabethkingia spp.

Results

Phylogenetic analysis revealed E. meningoseptica genomes from six countries distributed across different lineages, some of which persisted for years. The common resistome of these genomes included blaBlaB, blaCME, blaGOB, ranA/B, aadS, and catB (genes associated with resistance to β-lactams, aminoglycosides, and chloramphenicol). Some genomes also presented additional resistance genes (dfrA, ereD, blaVEB, aadS, and tet(X)). Interestingly, tet(X) and aadS were located in an ICE of 49 769 bp (ICEEmSQ101), which was fully obtained from the E. meningoseptica SQ101 genome. We also showed evidence that the other 27 genomes harboured this ICE. The distribution of ICEEmSQ101, carrying tet(X), was restricted to a single Chinese lineage.

Conclusions

The tet(X) gene is not prevalent in the species E. meningoseptica, as previously stated for the genus Elizabethkingia, since it is present only in a single Chinese lineage. We identified that several E. meningoseptica genomes harboured an ICE that mobilized the Elizabethkingia tet(X) gene and exhibited characteristics similar to the ICEs of other Flavobacteria, which would favour their transmission in this bacterial family.

目的:研究新出现的病原体伊丽莎白金格脑膜炎菌的 tet(X)基因及其与 ICE 的关系:研究新出现的病原体伊丽莎白金色葡萄球菌(Elizabethkingia meningoseptica)中决定替加环素抗性的 tet(X) 基因及其与 ICE 的关联:方法:利用 CARD 数据库检索并注释了美国国家科学与生物研究所(NCBI)的所有脑膜金线虫基因组(n=87),用于抗性组搜索,并根据脑膜金线虫核心基因组进行了系统发育分析。通过与伊丽莎白金线虫属(Elizabethkingia spp.)中出现的 ICE 进行比较基因组学鉴定:系统发生分析表明,来自六个国家的脑膜脑炎病毒基因组分布在不同的系谱中,其中一些系谱已存在多年。这些基因组的共同抗性基因组包括 blaBlaB、blaCME、blaGOB、ranA/B、aadS 和 catB(与对 β-内酰胺类、氨基糖苷类和氯霉素的抗性有关的基因)。一些基因组还出现了额外的抗性基因(dfrA、ereD、blaVEB、aadS 和 tet(X))。有趣的是,tet(X)和 aadS 基因位于一个 49 769 bp 的 ICE(ICEEmSQ101)中,该 ICE 完全来自脑膜塞菌 SQ101 基因组。我们还提出了其他 27 个基因组也存在该 ICE 的证据。携带tet(X)基因的ICEEmSQ101的分布仅限于一个中国品系:结论:tet(X)基因在脑膜脑炎伊丽莎白金线虫中并不普遍,这与之前伊丽莎白金线虫属的情况不同,因为它基本上只存在于一个中国品系中。我们发现,脑膜色素梭菌的几个基因组中都含有能调动 tet(X)基因的 ICE,并表现出与其他黄杆菌的 ICE 相似的特征,这有利于它们在该细菌家族中的传播。
{"title":"Prevalence and characterization of an integrative and conjugative element carrying tet(X) gene in Elizabethkingia meningoseptica","authors":"","doi":"10.1016/j.jgar.2024.07.001","DOIUrl":"10.1016/j.jgar.2024.07.001","url":null,"abstract":"<div><h3>Objectives</h3><p>To investigate the <em>tet</em>(X) gene, a determinant of tigecycline resistance, in the emerging pathogen <em>Elizabethkingia meningoseptica</em> and its association with an integrative and conjugative element (ICE).</p></div><div><h3>Methods</h3><p><em>All E. meningoseptica</em> genomes from the National Center for Biotechnology Information (<em>n</em> = 87) were retrieved and annotated for resistome searches using the CARD database. A phylogenic analysis was performed based on the <em>E. meningoseptica</em> core genome<em>.</em> The ICE was identified through comparative genomics with other ICEs occurring in <em>Elizabethkingia</em> spp.</p></div><div><h3>Results</h3><p>Phylogenetic analysis revealed <em>E. meningoseptica</em> genomes from six countries distributed across different lineages, some of which persisted for years. The common resistome of these genomes included <em>bla</em><sub>BlaB</sub>, <em>bla</em><sub>CME</sub>, <em>bla</em><sub>GOB</sub>, <em>ran</em>A/B, <em>aad</em>S, and <em>cat</em>B (genes associated with resistance to β-lactams, aminoglycosides, and chloramphenicol). Some genomes also presented additional resistance genes (<em>dfr</em>A, <em>ere</em>D, <em>bla</em><sub>VEB</sub>, <em>aad</em>S, and <em>tet</em>(X)). Interestingly, <em>tet</em>(X) and <em>aad</em>S were located in an ICE of 49 769 bp (ICEEmSQ101), which was fully obtained from the <em>E. meningoseptica</em> SQ101 genome. We also showed evidence that the other 27 genomes harboured this ICE. The distribution of ICEEmSQ101, carrying <em>tet</em>(X), was restricted to a single Chinese lineage.</p></div><div><h3>Conclusions</h3><p>The <em>tet</em>(X) gene is not prevalent in the species <em>E. meningoseptica</em>, as previously stated for the genus <em>Elizabethkingia</em>, since it is present only in a single Chinese lineage. We identified that several <em>E. meningoseptica</em> genomes harboured an ICE that mobilized the <em>Elizabethkingia tet</em>(X) gene and exhibited characteristics similar to the ICEs of other <em>Flavobacteria</em>, which would favour their transmission in this bacterial family.</p></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213716524001322/pdfft?md5=92abea5f89a5b94615fef94dba806c60&pid=1-s2.0-S2213716524001322-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic elements harbouring oxazolidinone resistance genes detected in swine enterococci circulate in clinical isolates, Italy 在猪肠球菌中检测到的含有恶唑烷酮抗性基因的遗传因子在意大利的临床分离物中循环。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-14 DOI: 10.1016/j.jgar.2024.06.016
{"title":"Genetic elements harbouring oxazolidinone resistance genes detected in swine enterococci circulate in clinical isolates, Italy","authors":"","doi":"10.1016/j.jgar.2024.06.016","DOIUrl":"10.1016/j.jgar.2024.06.016","url":null,"abstract":"","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213716524001292/pdfft?md5=1a543ced99be3ea382d3780d3d8a7b5e&pid=1-s2.0-S2213716524001292-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of multidrug-resistant hypervirulent Klebsiella pneumoniae strains ST29 and K212 harbouring tmexC2-tmexD2-toprJ2 ST29 和 K212 型耐多药高病毒性肺炎克雷伯氏菌携带 tmexC2-tmexD2-toprJ2 的特征。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-14 DOI: 10.1016/j.jgar.2024.06.014

Objectives

This study aimed to characterize a tigecycline-resistant hypervirulent Klebsiella pneumoniae (HvKP) strain, identified as KLZT, which carries the tigecycline resistance gene cluster tmexC2-tmexD2-toprJ2 belonging to ST29 and serotype K212.

Methods

Antimicrobial susceptibility and virulence phenotypes were assessed, followed by whole-genome sequencing (WGS) using PacBio II and MiSeq sequencers. Genome annotation was carried out using the RAST server and bioinformatics analysis revealed the genetic characteristics of this strain.

Results

Antimicrobial and virulence phenotype testing indicated that K. pneumoniae strain KLZT could be considered as a multidrug-resistant HvKP. WGS analysis showed that KLZT has a single 5,536,506-bp chromosome containing three plasmids 290,963 bp (pKLZT-1), 199,302 bp (pKLZT-2), and 4820 bp (pKLZT-3) in size, and also includes the ST29 and K212 serotypes. Four (blaSHV-187, oqxA, oqxB, and fosA6) and six resistance genes (tmexC2-tmxeD2-toprJ2, blaOXA-1, aac(6′)-Ib-cr, catB3, arr-3, and blaLEN27) were identified from chromosomal and plasmid pKLZT-1, respectively. Gene-based analysis of the resistance genes of plasmid pKLZT-1 showed that the tigecycline resistance gene cluster-carrying region was flanked by umuC and umuD (umuD-hps-IS5-tmexC2-tmexD2-toprJ2-umuC), as well as other resistance genes and virulence factors (ureB, ureC, and ureG), which were carried by IS5075-Tn3-intI1 -aac(6′)-Ib-cr-blaOXA-1-catB3-arr-3-blaLEN27-Tn3-ISkpn26-ureBCG-IS5075.

Conclusions

WGS has revealed that a multidrug-resistant strain, HvKP KLZT, belonging to ST29 with capsular serotype K212, contains a multidrug-resistance plasmid.

背景:本研究旨在鉴定一株对替加环素耐药的高病毒性肺炎克雷伯氏菌(HvKP)菌株的特征,该菌株被鉴定为KLZT,携带替加环素耐药基因簇tmexC2-tmexD2-toprJ2,属于ST29和血清型K212:使用 PacBio II 和 MiSeq 测序仪对抗菌药敏感性和毒力表型进行评估,然后进行全基因组测序(WGS)。使用 RAST 服务器进行了基因组注释,生物信息学分析揭示了该菌株的遗传特征:结果:抗菌和毒力表型测试表明,肺炎克雷伯菌株 KLZT 可被视为多重耐药 HvKP。WGS分析表明,该菌株有一条5,536,506bp的染色体,包含3个质粒,大小分别为290963bp(pKLZT-1)、199,302bp(pKLZT-2)和4820bp(pKLZT-3)。KLZT 被分为 ST29 和 K212 血清型。从染色体和质粒pKLZT-1中分别鉴定出5个(blaSHV-187、oqxA、oqxB、fosA6)和6个抗性基因(tmexC2-tmxeD2-toprJ2、blaOXA-1、aac(6')-Ib-cr、catB3、arr-3和blaLEN27)。质粒 pKLZT-1 的抗性基因遗传背景分析表明,替加环素抗性基因簇携带区两侧分别是 umuC 和 umuD(umuD-hps-IS5-tmexC2-tmexD2-toprJ2-umuC)以及其他抗性基因和毒力因子(ureB、IS5075-Tn3-intI1-aac(6')-Ib-cr-blaOXA-1-catB3-arr-3-blaLEN27-Tn3-ISkpn26-ureBCG-IS5075)携带。结论:在此,我们介绍了一种对多种药物耐药的 HvKP KLZT 的 WGS 研究结果,该 HvKP KLZT 属于 ST29,其囊膜血清型 K212 含有一种突变耐药质粒。
{"title":"Characteristics of multidrug-resistant hypervirulent Klebsiella pneumoniae strains ST29 and K212 harbouring tmexC2-tmexD2-toprJ2","authors":"","doi":"10.1016/j.jgar.2024.06.014","DOIUrl":"10.1016/j.jgar.2024.06.014","url":null,"abstract":"<div><h3>Objectives</h3><p>This study aimed to characterize a tigecycline-resistant hypervirulent <em>Klebsiella pneumoniae</em> (HvKP) strain, identified as KLZT, which carries the tigecycline resistance gene cluster <em>tmexC2-tmexD2-toprJ2</em> belonging to ST29 and serotype K212.</p></div><div><h3>Methods</h3><p>Antimicrobial susceptibility and virulence phenotypes were assessed, followed by whole-genome sequencing (WGS) using PacBio II and MiSeq sequencers. Genome annotation was carried out using the RAST server and bioinformatics analysis revealed the genetic characteristics of this strain.</p></div><div><h3>Results</h3><p>Antimicrobial and virulence phenotype testing indicated that <em>K. pneumoniae</em> strain KLZT could be considered as a multidrug-resistant HvKP. WGS analysis showed that KLZT has a single 5,536,506-bp chromosome containing three plasmids 290,963 bp (pKLZT-1), 199,302 bp (pKLZT-2), and 4820 bp (pKLZT-3) in size, and also includes the ST29 and K212 serotypes. Four (<em>bla</em><sub>SHV-187</sub>, <em>oqxA, oqxB</em>, and <em>fosA6</em>) and six resistance genes (<em>tmexC2-tmxeD2-toprJ2, bla</em><sub>OXA-1</sub>, <em>aac(6′)-Ib-cr, catB3, arr-3</em>, and <em>bla</em><sub>LEN27</sub>) were identified from chromosomal and plasmid pKLZT-1, respectively. Gene-based analysis of the resistance genes of plasmid pKLZT-1 showed that the tigecycline resistance gene cluster-carrying region was flanked by <em>umuC</em> and <em>umuD</em> (<em>umuD</em>-<em>hps</em>-<em>IS5</em>-<em>tmexC2-tmexD2-toprJ2</em>-<em>umuC</em>), as well as other resistance genes and virulence factors (<em>ureB, ureC</em>, and <em>ureG</em>), which were carried by <em>IS5075</em>-<em>Tn3-intI1 -aac(6′)-Ib-cr-bla</em><sub>OXA-1</sub><em>-catB3-arr-3-bla</em><sub>LEN27</sub><em>-Tn3-ISkpn26-ureBCG-IS5075</em>.</p></div><div><h3>Conclusions</h3><p>WGS has revealed that a multidrug-resistant strain, HvKP KLZT, belonging to ST29 with capsular serotype K212, contains a multidrug-resistance plasmid.</p></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221371652400122X/pdfft?md5=4ff437c688ce99f06347d0313582ae8a&pid=1-s2.0-S221371652400122X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141603754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insertion with long target duplication in polymyxin B-induced resistant mutant of Salmonella 多粘菌素 B 诱导的沙门氏菌耐药突变体中的长目标重复插入。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-14 DOI: 10.1016/j.jgar.2024.07.002

Objectives

A Salmonella enterica subsp. diarizonae (hereafter S. diarizonae) clinical strain S499 demonstrated unique genomic features. The strain S499 was treated with polymyxin B in vitro to investigate the mechanism of resistance.

Methods

S499 was treated with polymyxin B by increasing concentration gradually to obtain a resistant mutant S499V. Whole genomes of the two strains were sequenced using Illumina HiSeq X-10 and PacBio RS II platforms. Reverse transcription–quantitative polymerase chain reaction (RT-qPCR) was performed to compare the gene expression.

Results

The chromosome of strain S499 contained a 40-kb DNA region that was replicated after treatment with polymyxin B and generated a triple tandem DNA repeat region in the chromosome of mutant strain S499V. This repeat region in S499V was flanked by IS1 and contained pmrD, pmrG, and arnBCADTEF operon. In comparison to the homologous 40-kb DNA region of strain S499, a few genes in the repeat DNA region of strain S499V contained truncating mutations that generate two open reading frames (ORFs). The expression of pmrD, pmrG, and arnT was significantly upregulated in S499V.

Conclusion

The duplication and overexpression of pmrD, pmrG, and arnT operon may be responsible for the polymyxin B resistance of mutant strain S499V.

目的:肠炎沙门氏菌 diarizonae 亚种(以下简称 diarizonae)临床菌株 S499 具有独特的基因组特征。在体外用多粘菌素 B 处理 S499 菌株,以研究其耐药性机制:方法:用多粘菌素 B 处理 S499,逐渐增加浓度,以获得抗性突变体 S499V。使用 Illumina HiSeq X-10 和 PacBio RS II 平台对两株菌株的全基因组进行测序。对基因表达进行了反转录定量 PCR(RT-qPCR)比较:结果:菌株 S499 的染色体包含一个 40 kb 的 DNA 区域,经多粘菌素 B 处理后复制,在突变菌株 S499V 的染色体中产生了一个三重串联 DNA 重复区域。S499V 的这一重复区两侧是 IS1,包含 pmrD、pmrG 和 arnBCADTEF 操作子。与菌株 S499 的同源 40-kb DNA 区域相比,菌株 S499V 重复 DNA 区域中的一些基因含有截短突变,产生了两个开放阅读框(ORF)。在 S499V 中,pmrD、pmrG 和 arnT 的表达显著上调:结论:pmrD、pmrG 和 arnT 操作子的重复和过度表达可能是突变株 S499V 对多粘菌素 B 产生抗性的原因。
{"title":"Insertion with long target duplication in polymyxin B-induced resistant mutant of Salmonella","authors":"","doi":"10.1016/j.jgar.2024.07.002","DOIUrl":"10.1016/j.jgar.2024.07.002","url":null,"abstract":"<div><h3>Objectives</h3><p>A <em>Salmonella enterica</em> subsp. <em>diarizonae</em> (hereafter <em>S. diarizonae</em>) clinical strain S499 demonstrated unique genomic features. The strain S499 was treated with polymyxin B in vitro to investigate the mechanism of resistance.</p></div><div><h3>Methods</h3><p>S499 was treated with polymyxin B by increasing concentration gradually to obtain a resistant mutant S499V. Whole genomes of the two strains were sequenced using Illumina HiSeq X<strong>-</strong>10 and PacBio RS II platforms. Reverse transcription–quantitative polymerase chain reaction (RT-qPCR) was performed to compare the gene expression.</p></div><div><h3>Results</h3><p>The chromosome of strain S499 contained a 40-kb DNA region that was replicated after treatment with polymyxin B and generated a triple tandem DNA repeat region in the chromosome of mutant strain S499V. This repeat region in S499V was flanked by IS<em>1</em> and contained <em>pmrD, pmrG</em>, and <em>arnBCADTEF</em> operon<em>.</em> In comparison to the homologous 40-kb DNA region of strain S499, a few genes in the repeat DNA region of strain S499V contained truncating mutations that generate two open reading frames (ORFs). The expression of <em>pmrD, pmrG</em>, and <em>arnT</em> was significantly upregulated in S499V.</p></div><div><h3>Conclusion</h3><p>The duplication and overexpression of <em>pmrD, pmrG</em>, and <em>arnT</em> operon may be responsible for the polymyxin B resistance of mutant strain S499V.</p></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213716524001334/pdfft?md5=b614bd4747185be867b00655dbb4f751&pid=1-s2.0-S2213716524001334-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141620160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colistin resistance in ESBL- and Carbapenemase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Cambodia 柬埔寨产ESBL和碳青霉烯酶大肠埃希菌和肺炎克雷伯氏菌临床分离菌株对可乐定的耐药性。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-14 DOI: 10.1016/j.jgar.2024.06.017

Objectives

Despite the critical importance of colistin as a last-resort antibiotic, limited studies have investigated colistin resistance in human infections in Cambodia. This study aimed to investigate the colistin resistance and its molecular determinants among Extended-spectrum beta-lactamase (ESBL)- and carbapenemase-producing (CP) Klebsiella pneumoniae (K. pneumoniae) and Escherichia coli (E. coli) isolated in Cambodia between 2016 and 2020.

Methods

E. coli (n = 223) and K. pneumoniae (n = 39) were tested for colistin minimum inhibitory concentration (MIC) by broth microdilution. Resistant isolates were subjected to polymerase chain reaction (PCR) for detection of mobile colistin resistance genes (mcr) and chromosomal mutations in the two-component system (TCS).

Results

Eighteen isolates (10 K. pneumoniae and 8 E. coli) revealed colistin resistance with a rate of 5.9% in E. coli and 34.8% in K. pneumoniae among ESBL isolates, and 1% in E. coli and 12.5% in K. pneumoniae among CP isolates. The resistance was associated with mcr variants (13/18 isolates, mcr-1, mcr-3, and mcr-8.2) and TCS mutations within E. coli and K. pneumoniae, with the first detection of mcr-8.2 in Cambodia, the discovery of new mutations potentially associated to colistin resistance in the TCS of E. coli (PhoP I47V, PhoQ N352K, PmrB G19R, and PmrD G85R) and the co-occurrence of mcr genes and colistin resistance conferring TCS mutations in 11 of 18 isolates.

Conclusions

The findings highlight the presence of colistin resistance in ESBL- and CP- Enterobacteriaceae involved in human infections in Cambodia as well as chromosomal mutations in TCS and the emergence of mcr-8.2 in E. coli and K. pneumoniae. It underscores the need for continuous surveillance, antimicrobial stewardship, and control measures to mitigate the spread of colistin resistance.

目的: 。尽管可乐定作为最后的抗生素至关重要,但对柬埔寨人类感染中可乐定耐药性的研究却十分有限。本研究旨在调查 2016 年至 2020 年期间在柬埔寨分离的广谱β-内酰胺酶(ESBL)和产碳青霉烯酶(CP)肺炎克雷伯菌(KP)和大肠埃希菌(EC)对可乐定的耐药性及其分子决定因素。通过肉汤微量稀释法检测大肠埃希菌(n=223)和肺炎克雷伯菌(n=39)的可乐定最低抑菌浓度(MIC)。对耐药分离物进行聚合酶链式反应(PCR),检测移动的可乐定耐药基因(mcr)和双组分系统(TCS)的染色体突变。18个分离株(10个KP,8个EC)显示出对可乐定的耐药性,ESBL分离株中,EC株的耐药率为5.9%,KP株的耐药率为34.8%;CP分离株中,EC株的耐药率为1%,KP株的耐药率为12.5%。耐药性与 mcr 变异(13/18 个分离株,mcr-1、mcr-3 和 mcr-8.2)以及欧共体和金边省的 TCS 变异有关,其中 mcr-8.2 是首次在柬埔寨发现。在柬埔寨首次发现了 mcr-8.2,在 EC 的 TCS 中发现了可能与耐大肠菌素有关的新突变(PhoP I47V、PhoQ N352K、PmrB G19R、PmrD G85R),在 11/18 个分离株中同时发现了 mcr 基因和耐大肠菌素的 TCS 突变:研究结果表明,柬埔寨涉及人类感染的 ESBL- 和 CP- 肠杆菌科细菌中存在对可乐定的耐药性、TCS 染色体突变以及在 EC 和 KP 中出现 mcr-8.2。这凸显了持续监测、抗菌药物管理和控制措施的必要性,以减少可乐定耐药性的传播。
{"title":"Colistin resistance in ESBL- and Carbapenemase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Cambodia","authors":"","doi":"10.1016/j.jgar.2024.06.017","DOIUrl":"10.1016/j.jgar.2024.06.017","url":null,"abstract":"<div><h3>Objectives</h3><p>Despite the critical importance of colistin as a last-resort antibiotic, limited studies have investigated colistin resistance in human infections in Cambodia. This study aimed to investigate the colistin resistance and its molecular determinants among Extended-spectrum beta-lactamase (ESBL)- and carbapenemase-producing (CP) <em>Klebsiella pneumoniae</em> (<em>K. pneumoniae</em>) and <em>Escherichia coli</em> (<em>E. coli</em>) isolated in Cambodia between 2016 and 2020.</p></div><div><h3>Methods</h3><p><em>E. coli</em> (<em>n</em> = 223) and <em>K. pneumoniae</em> (<em>n</em> = 39) were tested for colistin minimum inhibitory concentration (MIC) by broth microdilution. Resistant isolates were subjected to polymerase chain reaction (PCR) for detection of mobile colistin resistance genes (<em>mcr</em>) and chromosomal mutations in the two-component system (TCS).</p></div><div><h3>Results</h3><p>Eighteen isolates (10 <em>K. pneumoniae</em> and 8 <em>E. coli</em>) revealed colistin resistance with a rate of 5.9% in <em>E. coli</em> and 34.8% in <em>K. pneumoniae</em> among ESBL isolates, and 1% in <em>E. coli</em> and 12.5% in <em>K. pneumoniae</em> among CP isolates. The resistance was associated with <em>mcr</em> variants (13/18 isolates, <em>mcr-1, mcr</em>-<em>3</em>, and <em>mcr-8.2</em>) and TCS mutations within <em>E. coli</em> and <em>K. pneumoniae</em>, with the first detection of <em>mcr-8.2</em> in Cambodia, the discovery of new mutations potentially associated to colistin resistance in the TCS of <em>E. coli</em> (PhoP I47V, PhoQ N352K, PmrB G19R, and PmrD G85R) and the co-occurrence of <em>mcr</em> genes and colistin resistance conferring TCS mutations in 11 of 18 isolates.</p></div><div><h3>Conclusions</h3><p>The findings highlight the presence of colistin resistance in ESBL- and CP- <em>Enterobacteriaceae</em> involved in human infections in Cambodia as well as chromosomal mutations in TCS and the emergence of <em>mcr</em>-<em>8.2</em> in <em>E. coli</em> and <em>K. pneumoniae</em>. It underscores the need for continuous surveillance, antimicrobial stewardship, and control measures to mitigate the spread of colistin resistance.</p></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213716524001346/pdfft?md5=baecadd2c501f3b5b9504df2e7990299&pid=1-s2.0-S2213716524001346-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transmission of global clones of NDM-producing Enterobacterales and interspecies spread of IncX3 plasmid harbouring blaNDM-5 in Tokyo 东京产NDM肠杆菌全球克隆的传播和携带blaNDM-5的IncX3质粒的种间传播。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-14 DOI: 10.1016/j.jgar.2024.06.020

Objective

The aim of this study is to characterise the molecular characteristics of NDM-producing Enterobacterales, which have been on the increase in recent years in Japan, where IMP-producing bacteria are dominant among carbapenemase-producing Enterobacterales.

Methods

We collected 21 strains of NDM-producing Enterobacterales detected between 2015 and 2022 at five hospitals in Tokyo and performed illumina whole genome sequencing. For the seven selected strains, nanopore long-read sequencing was also performed to characterise the plasmids harbouring blaNDM.

Results

Fourteen strains were Escherichia coli and all carried blaNDM-5. Among these strains, eight and three were sequence type (ST) 410 and ST167, respectively, and both groups of strains were spread clonally in different hospitals. Two strains of Klebsiella pneumoniae ST147 carrying blaNDM-1 were detected in a hospital, and these strains had also spread clonally. The remainder included Enterobacter hormaechei, Klebsiella quasipneumoniae, Citrobacter amalonaticus, and Klebsiella michiganensis. Plasmid analysis revealed that an identical IncX3 plasmid harbouring blaNDM-5 was shared among four strains of different bacterial species (E. coli, C. amalonaticus, K. michiganensis, and E. hormaechei) detected at the same hospital. In addition, a Klebsiella quasipneumoniae strain detected at a different hospital also carried an IncX3 plasmid with a similar genetic structure.

Conclusions

Nosocomial spread of multiple multidrug-resistant global clones and transmission of IncX3 plasmids harbouring blaNDM-5 among multiple species were detected as the major pathways of spread of NDM-producing Enterobacterales in Tokyo. Early detection of carriers and measures to prevent nosocomial spread are important to prevent further spread of NDM-producing organisms.

研究目的本研究旨在描述近年来在日本呈上升趋势的产 NDM 肠杆菌的分子特征,在产碳青霉烯酶肠杆菌中,产 IMP 菌占主导地位:我们收集了 2015 年至 2022 年期间在东京五家医院检测到的 21 株产 NDM 肠杆菌,并进行了 illumina 全基因组测序。我们还对所选的 7 株菌株进行了纳米孔长读数测序,以确定携带 blaNDM 的质粒的特征:结果:14 株大肠杆菌均携带 blaNDM-5。在这些菌株中,分别有 8 株和 3 株属于序列类型(ST)410 和 ST167,这两类菌株在不同的医院中克隆传播。在一家医院检测到两株携带 blaNDM-1 的 ST147 型肺炎克雷伯氏菌,这些菌株也是克隆传播的。其余菌株包括霍拉氏肠杆菌、准肺炎克雷伯菌、枸橼酸杆菌和密歇根克雷伯菌。质粒分析表明,在同一家医院检测到的四株不同种类的细菌(大肠杆菌、丙型肝炎杆菌、密歇根克雷伯菌和霍拉氏肠杆菌)共用一个相同的IncX3质粒,该质粒携带blaNDM-5。此外,在另一家医院检测到的一株类肺炎克雷伯氏菌也携带有基因结构类似的 IncX3 质粒:结论:多重耐药性全球克隆的院内传播和携带 blaNDM-5 的 IncX3 质粒在多个菌种间的传播是东京产 NDM 肠杆菌传播的主要途径。及早发现带菌者并采取措施防止医院内传播,对于防止产NDM菌的进一步传播非常重要。
{"title":"Transmission of global clones of NDM-producing Enterobacterales and interspecies spread of IncX3 plasmid harbouring blaNDM-5 in Tokyo","authors":"","doi":"10.1016/j.jgar.2024.06.020","DOIUrl":"10.1016/j.jgar.2024.06.020","url":null,"abstract":"<div><h3>Objective</h3><p>The aim of this study is to characterise the molecular characteristics of NDM-producing <em>Enterobacterales</em>, which have been on the increase in recent years in Japan, where IMP-producing bacteria are dominant among carbapenemase-producing <em>Enterobacterales</em>.</p></div><div><h3>Methods</h3><p>We collected 21 strains of NDM-producing <em>Enterobacterales</em> detected between 2015 and 2022 at five hospitals in Tokyo and performed illumina whole genome sequencing. For the seven selected strains, nanopore long-read sequencing was also performed to characterise the plasmids harbouring <em>bla</em><sub>NDM</sub>.</p></div><div><h3>Results</h3><p>Fourteen strains were <em>Escherichia coli</em> and all carried <em>bla</em><sub>NDM-5</sub>. Among these strains, eight and three were sequence type (ST) 410 and ST167, respectively, and both groups of strains were spread clonally in different hospitals. Two strains of <em>Klebsiella pneumoniae</em> ST147 carrying <em>bla</em><sub>NDM-1</sub> were detected in a hospital, and these strains had also spread clonally. The remainder included <em>Enterobacter hormaechei, Klebsiella quasipneumoniae, Citrobacter amalonaticus</em>, and <em>Klebsiella michiganensis</em>. Plasmid analysis revealed that an identical IncX3 plasmid harbouring <em>bla</em><sub>NDM-5</sub> was shared among four strains of different bacterial species (<em>E. coli, C. amalonaticus, K. michiganensis</em>, and <em>E. hormaechei</em>) detected at the same hospital. In addition, a <em>Klebsiella quasipneumoniae</em> strain detected at a different hospital also carried an IncX3 plasmid with a similar genetic structure.</p></div><div><h3>Conclusions</h3><p>Nosocomial spread of multiple multidrug-resistant global clones and transmission of IncX3 plasmids harbouring <em>bla</em><sub>NDM-5</sub> among multiple species were detected as the major pathways of spread of NDM-producing <em>Enterobacterales</em> in Tokyo. Early detection of carriers and measures to prevent nosocomial spread are important to prevent further spread of NDM-producing organisms.</p></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213716524001310/pdfft?md5=770ef3f488ae2c9343374e33d636e4fd&pid=1-s2.0-S2213716524001310-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro evaluation of using ceftazidime/avibactam against carbapenem-resistant Acinetobacter baumannii 使用头孢唑肟/阿维巴坦抗耐碳青霉烯类鲍曼不动杆菌的体外评估。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-10 DOI: 10.1016/j.jgar.2024.06.011

Objective

Carbapenem-resistant Acinetobacter baumannii (CRAB) is a global concern as effective treatments are very limited. We previously used a modified susceptibility testing approach to predict growth suppression in carbapenem-resistant Enterobacterales, but there are uncertainties about the generalizability of the model. The objective of this study is to verify if a similar approach can be extended to CRAB.

Method

A clinical isolate of CRAB resistant to ceftazidime/avibactam (CAZ/AVI, MIC = 32/4 mg/L) was examined. CAZ susceptibility was determined using increasing concentrations of AVI (0–64 mg/L), and MIC reduction was characterized with a sigmoid inhibitory maximum effect (Emax) model. The effectiveness of CAZ/AVI was validated in a hollow fibre infection model (HFIM) over 72 hours, using simulated unbound serum / epithelial lining fluid (ELF) exposures of 2.5 g over 2 hours every 8 hours. Baseline inocula of approximately 5.5 log CFU/mL were examined.

Results

An AVI concentration-dependent reduction in CAZ MIC was observed (r2 = 0.99). CAZ MIC was dramatically reduced from 512 mg/L (no AVI) to 32 mg/L (AVI = 4 mg/L), and further to 8 mg/L (AVI = 16 mg/L). Pharmacokinetic simulations were satisfactory in the HFIM (r2 > 0.96). Bacterial suppression was observed >24 hours with the serum exposure, but not that from the ELF.

Conclusion

Using multiple AVI concentrations within the clinically relevant range, our susceptibility testing approach could have better insights of treatment outcome for infections caused by CRAB. This could potentially lead to effective intervention(s) overlooked by conventional susceptibility testing method. This case highlights the importance of site-specific drug exposures on determining treatment outcome.

目的:耐碳青霉烯类鲍曼不动杆菌(CRAB)是一个全球关注的问题,因为有效的治疗方法非常有限。我们以前曾使用一种改良的药敏试验方法来预测耐碳青霉烯类肠杆菌的生长抑制情况,但该模型的通用性还存在不确定性。本研究的目的是验证能否将类似方法扩展到 CRAB:方法:研究了对头孢他啶/阿维菌素(CAZ/AVI,MIC=32/4 mg/L)耐药的CRAB临床分离株。使用浓度不断升高的 AVI(0-64 mg/L)测定对 CAZ 的敏感性,MIC 值的降低采用乙叉抑制最大效应(Emax)模型进行表征。在中空纤维感染模型(HFIM)中,使用模拟非结合血清/上皮内衬液(ELF)暴露 2.5 克,每 8 小时暴露 2 小时,经过 72 小时验证了 CAZ/AVI 的有效性。检测的基线接种量约为 5.5 log CFU/mL:结果:观察到 AVI 浓度依赖性降低 CAZ MIC(r2=0.99)。头孢他啶的 MIC 从 512 mg/L(无 AVI)大幅降至 32 mg/L(AVI=4 mg/L),并进一步降至 8 mg/L(AVI=16 mg/L)。HFIM 中的药代动力学模拟结果令人满意(r2>0.96)。通过血清暴露观察到细菌抑制作用大于 24 小时,但 ELF 则没有:结论:使用临床相关范围内的多种 AVI 浓度,我们的药敏试验方法可以更好地了解 CRAB 引起的感染的治疗结果。这有可能导致传统药敏试验方法所忽视的有效干预。本病例强调了特定部位药物暴露对决定治疗结果的重要性。
{"title":"In vitro evaluation of using ceftazidime/avibactam against carbapenem-resistant Acinetobacter baumannii","authors":"","doi":"10.1016/j.jgar.2024.06.011","DOIUrl":"10.1016/j.jgar.2024.06.011","url":null,"abstract":"<div><h3>Objective</h3><p>Carbapenem-resistant <em>Acinetobacter baumannii</em> (CRAB) is a global concern as effective treatments are very limited. We previously used a modified susceptibility testing approach to predict growth suppression in carbapenem-resistant <em>Enterobacterales</em>, but there are uncertainties about the generalizability of the model. The objective of this study is to verify if a similar approach can be extended to CRAB.</p></div><div><h3>Method</h3><p>A clinical isolate of CRAB resistant to ceftazidime/avibactam (CAZ/AVI, MIC = 32/4 mg/L) was examined. CAZ susceptibility was determined using increasing concentrations of AVI (0–64 mg/L), and MIC reduction was characterized with a sigmoid inhibitory maximum effect (Emax) model. The effectiveness of CAZ/AVI was validated in a hollow fibre infection model (HFIM) over 72 hours, using simulated unbound serum / epithelial lining fluid (ELF) exposures of 2.5 g over 2 hours every 8 hours. Baseline inocula of approximately 5.5 log CFU/mL were examined.</p></div><div><h3>Results</h3><p>An AVI concentration-dependent reduction in CAZ MIC was observed (r<sup>2</sup> = 0.99). CAZ MIC was dramatically reduced from 512 mg/L (no AVI) to 32 mg/L (AVI = 4 mg/L), and further to 8 mg/L (AVI = 16 mg/L). Pharmacokinetic simulations were satisfactory in the HFIM (r<sup>2</sup> &gt; 0.96). Bacterial suppression was observed &gt;24 hours with the serum exposure, but not that from the ELF.</p></div><div><h3>Conclusion</h3><p>Using multiple AVI concentrations within the clinically relevant range, our susceptibility testing approach could have better insights of treatment outcome for infections caused by CRAB. This could potentially lead to effective intervention(s) overlooked by conventional susceptibility testing method. This case highlights the importance of site-specific drug exposures on determining treatment outcome.</p></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213716524001218/pdfft?md5=8babafd4c28563b4fc240c4092c9fde4&pid=1-s2.0-S2213716524001218-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141600229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mutations in the pmrB gene constitute the major mechanism underlying chromosomally encoded colistin resistance in clinical Escherichia coli pmrB 基因突变是临床大肠杆菌对染色体编码的可乐定产生抗药性的主要机制。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-10 DOI: 10.1016/j.jgar.2024.06.013

Objectives

The mechanisms underlying chromosomally encoded colistin resistance in Escherichia coli remain insufficiently investigated. In this study, we investigated the contribution of various pmrB mutations from E. coli clinical isolates to colistin resistance.

Methods

The resistance mechanisms in eight mcr-negative colistin-resistant E. coli isolates obtained from a nationwide surveillance program in Taiwan using recombinant DNA techniques and complementary experiments were investigated. The minimal inhibitory concentrations (MICs) of colistin in the recombinant strains were compared with those in the parental strains. The expression levels of pmrA and pmrK (which are part of the pmrCAB and pmrHFIJKLM operons associated with colistin resistance) were measured using reverse transcription-quantitative real-time polymerase chain reaction.

Results

In the complementation experiments, various mutated pmrB alleles from the eight mcr-negative colistin-resistant E. coli strains were introduced into an ATCC25922 mutant with a PmrB deletion, which resulted in colistin resistance. The MIC levels of colistin in the most complemented strains were comparable to those of the parental colistin-resistant strains. Increased expression levels of pmrA and pmrK were consistently detected in most complemented strains. The impact for colistin resistance was confirmed for various novel amino acid substitutions, P94L, G19E, L194P, L98R and R27L in PmrB from the parental clinical strains. The detected amino acid substitutions are distributed in the different functional domains of PmrB.

Conclusions

Colistin resistance mediated by amino acid substitutions in PmrB is a major chromosomally encoded mechanism in E. coli of clinical origin.

目的:对大肠埃希菌染色体编码的可乐定耐药性机制的研究仍然不足。本研究调查了大肠埃希菌临床分离株中各种 pmrB 突变对大肠菌素耐药性的贡献:方法:采用重组 DNA 技术和互补实验,研究了从台湾全国性监测项目中获得的 8 株 mcr 阴性耐大肠菌素大肠杆菌的耐药机制。将重组菌株与亲本菌株的可乐定最小抑菌浓度(MICs)进行了比较。利用反转录-实时定量聚合酶链反应测定了 pmrA 和 pmrK(与可乐定抗性相关的 pmrCAB 和 pmrHFIJKLM 操作子的一部分)的表达水平:结果:在互补实验中,将 8 株 mcr 阴性的耐大肠菌株中各种突变的 pmrB 等位基因导入 PmrB 缺失的 ATCC25922 突变体中,从而产生了对大肠菌素的耐药性。在大多数互补菌株中,可乐定的 MIC 水平与亲本可乐定耐药菌株相当。在大多数互补菌株中都检测到 pmrA 和 pmrK 表达水平的升高。来自亲本临床菌株的 PmrB 中的 P94L、G19E、L194P、L98R 和 R27L 等多个新型氨基酸置换对秋水仙素耐药性的影响得到了证实。检测到的氨基酸置换分布在 PmrB 的不同功能域:结论:由 PmrB 氨基酸置换介导的秋水仙碱耐药性是临床来源大肠杆菌的一种主要染色体编码机制。
{"title":"Mutations in the pmrB gene constitute the major mechanism underlying chromosomally encoded colistin resistance in clinical Escherichia coli","authors":"","doi":"10.1016/j.jgar.2024.06.013","DOIUrl":"10.1016/j.jgar.2024.06.013","url":null,"abstract":"<div><h3>Objectives</h3><p>The mechanisms underlying chromosomally encoded colistin resistance in <em>Escherichia coli</em> remain insufficiently investigated. In this study, we investigated the contribution of various <em>pmrB</em> mutations from <em>E. coli</em> clinical isolates to colistin resistance.</p></div><div><h3>Methods</h3><p>The resistance mechanisms in eight <em>mcr</em>-negative colistin-resistant <em>E. coli</em> isolates obtained from a nationwide surveillance program in Taiwan using recombinant DNA techniques and complementary experiments were investigated. The minimal inhibitory concentrations (MICs) of colistin in the recombinant strains were compared with those in the parental strains. The expression levels of <em>pmrA</em> and <em>pmrK</em> (which are part of the <em>pmrCAB</em> and <em>pmrHFIJKLM</em> operons associated with colistin resistance) were measured using reverse transcription-quantitative real-time polymerase chain reaction.</p></div><div><h3>Results</h3><p>In the complementation experiments, various mutated <em>pmrB</em> alleles from the eight <em>mcr</em>-negative colistin-resistant <em>E. coli</em> strains were introduced into an ATCC25922 mutant with a PmrB deletion, which resulted in colistin resistance. The MIC levels of colistin in the most complemented strains were comparable to those of the parental colistin-resistant strains. Increased expression levels of <em>pmrA</em> and <em>pmrK</em> were consistently detected in most complemented strains. The impact for colistin resistance was confirmed for various novel amino acid substitutions, P94L, G19E, L194P, L98R and R27L in PmrB from the parental clinical strains. The detected amino acid substitutions are distributed in the different functional domains of PmrB.</p></div><div><h3>Conclusions</h3><p>Colistin resistance mediated by amino acid substitutions in PmrB is a major chromosomally encoded mechanism in <em>E. coli</em> of clinical origin.</p></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213716524001231/pdfft?md5=b1f5d54d4b0a2ef910c7bd7fb1e956ad&pid=1-s2.0-S2213716524001231-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141600230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Occurrence of multi-carbapenemase-producing Enterobacterales in a tertiary hospital in Madrid (Spain): A new epidemiologic scenario 马德里(西班牙)一家三级医院出现产多种碳青霉烯酶的肠杆菌:一种新的流行病学情况。
IF 3.7 3区 医学 Q2 INFECTIOUS DISEASES Pub Date : 2024-07-10 DOI: 10.1016/j.jgar.2024.06.012

Introduction

Multi-carbapenemase-producing Enterobacterales (M-CPE) are increasingly described. We characterized the M-CPE isolates prospectively recovered in our hospital (Madrid, Spain) over two years (2021–2022).

Methods

We collected 796 carbapenem resistant Enterobacterales (CRE) from clinical and surveillance samples. Carbapenemase production was confirmed with phenotypic (immunochromatographic, disk diffusion) and molecular (PCR, WGS) techniques. Antimicrobial susceptibility was evaluated by a standard broth microdilution method. Clinical and demographic data were collected.

Results

Overall, 23 M-CPE (10 Klebsiella pneumoniae, 6 Citrobacter freundii complex, 3 Escherichia coli, 2 Klebsiella oxytoca, and 2 Enterobacter hormaechei) isolates were recovered from 17 patients (3% with CPE, 0.26-0.28 cases per 1000 admissions). OXA-48 + KPC-3 (7/23) and KPC-3 + VIM-1 (5/23) were the most frequent carbapenemase combinations. All patients had prior antibiotics exposure, including carbapenems (8/17). High resistance rates to ceftazidime/avibactam (14/23), imipenem/relebactam (16/23) and meropenem/vaborbactam (7/23) were found. Ceftazidime/avibactam + aztreonam combination was synergistic in all metallo-β-lactamase producers. Clonal and non-clonal related isolates were found, particularly in K. pneumoniae (5 ST29, 3 ST147, 3 ST307) and C. freundii (3 ST8, 2 ST125, 1 ST563). NDM-1 + OXA-48 was introduced with the ST147-K. pneumoniae high-risk clone linked to the transfer of a Ukrainian patient. We identified four possible nosocomial clonal transmission events between patients of the same clone with the same combination of carbapenemases (KPC-3 + VIM-1-ST29-K. pneumoniae, NDM-1 + OXA-48-ST147-K. pneumoniae and KPC-2 + VIM-1-ST145-K. oxytoca). Carbapenemase-encoding genes were located on different plasmids, except for VIM-1 + KPC-2-ST145-K. oxytoca. Cross-species transmission and a possible acquisition overtime was found, particularly between K. pneumoniae and E. coli producing OXA-48 + KPC-3.

Conclusion

M-CPE is an emerging threat in our hospital. Co-production of different carbapenemases, including metallo-β-lactamases, limits therapeutic options and depicts the need to reinforce infection control measures.

导言:产多种碳青霉烯酶的肠杆菌(M-CPE)越来越多。我们对两年内(2021-2022 年)在我院(西班牙马德里)发现的 M-CPE 分离菌进行了前瞻性鉴定:我们从临床和监测样本中收集了 796 株耐碳青霉烯类肠杆菌(CRE)。通过表型(免疫层析、磁盘扩散)和分子(PCR、WGS)技术确认了碳青霉烯酶的产生。抗菌药敏感性采用标准肉汤微量稀释法进行评估。收集了临床和人口统计学数据:总体而言,从 17 名患者(3% 患有 CPE,每 1000 例住院患者中有 0.27 例)中分离出 23 个 M-CPE (10 个肺炎克雷伯菌、6 个弗氏复合柠檬酸杆菌、3 个大肠埃希菌、2 个氧合克雷伯菌和 2 个荷尔玛氏肠杆菌)。OXA-48+KPC-3 (7/23) 和 KPC-3+VIM-1 (5/23) 是最常见的碳青霉烯酶组合。所有患者都曾接触过抗生素,包括碳青霉烯类(8/17)。对头孢他啶/阿维巴坦(14/23)、亚胺培南/雷巴坦(16/23)和美罗培南/伐巴内酰胺(7/23)的耐药率较高。头孢唑肟/阿维巴坦+阿卓萘胺组合对所有金属-β-内酰胺酶产生者均有协同作用。发现了克隆和非克隆相关分离株,尤其是肺炎双球菌(5 株 ST29、3 株 ST147、3 株 ST307)和弗氏球菌(3 株 ST8、2 株 ST125、1 株 ST563)。NDM-1+OXA-48 是与一名乌克兰病人转院时感染的 ST147-K.肺炎球菌高危克隆一起引入的。我们发现了四种可能发生在具有相同碳青霉烯酶组合的同一克隆(KPC-3+VIM-1-ST29-K. pneumoniae、NDM-1+OXA-48-ST147-K. pneumoniae 和 KPC-2+VIM-1-ST145-K. oxytoca)患者之间的院内克隆传播事件。除 VIM-1+KPC-2-ST145-K. oxytoca 外,碳青霉烯酶编码基因位于不同的质粒上。研究发现,肺炎克雷伯菌与产生 OXA-48+KPC-3 的大肠杆菌之间存在跨种传播和可能的超时获取:结论:M-CPE 是我们医院新出现的一种威胁。不同碳青霉烯酶(包括金属-β-内酰胺酶)的共同产生限制了治疗方案的选择,说明有必要加强感染控制措施。
{"title":"Occurrence of multi-carbapenemase-producing Enterobacterales in a tertiary hospital in Madrid (Spain): A new epidemiologic scenario","authors":"","doi":"10.1016/j.jgar.2024.06.012","DOIUrl":"10.1016/j.jgar.2024.06.012","url":null,"abstract":"<div><h3>Introduction</h3><p>Multi-carbapenemase-producing Enterobacterales (M-CPE) are increasingly described. We characterized the M-CPE isolates prospectively recovered in our hospital (Madrid, Spain) over two years (2021–2022).</p></div><div><h3>Methods</h3><p>We collected 796 carbapenem resistant Enterobacterales (CRE) from clinical and surveillance samples. Carbapenemase production was confirmed with phenotypic (immunochromatographic, disk diffusion) and molecular (PCR, WGS) techniques. Antimicrobial susceptibility was evaluated by a standard broth microdilution method. Clinical and demographic data were collected.</p></div><div><h3>Results</h3><p>Overall, 23 M-CPE (10 <em>Klebsiella pneumoniae</em>, 6 <em>Citrobacter freundii complex, 3 Escherichia coli, 2 Klebsiella oxytoca,</em> and 2 <em>Enterobacter hormaechei</em>) isolates were recovered from 17 patients (3% with CPE, 0.26-0.28 cases per 1000 admissions). OXA-48 + KPC-3 (7/23) and KPC-3 + VIM-1 (5/23) were the most frequent carbapenemase combinations. All patients had prior antibiotics exposure, including carbapenems (8/17). High resistance rates to ceftazidime/avibactam (14/23), imipenem/relebactam (16/23) and meropenem/vaborbactam (7/23) were found. Ceftazidime/avibactam + aztreonam combination was synergistic in all metallo-β-lactamase producers. Clonal and non-clonal related isolates were found, particularly in <em>K. pneumoniae</em> (5 ST29, 3 ST147, 3 ST307) and <em>C. freundii</em> (3 ST8, 2 ST125, 1 ST563). NDM-1 + OXA-48 was introduced with the ST147-<em>K. pneumoniae</em> high-risk clone linked to the transfer of a Ukrainian patient. We identified four possible nosocomial clonal transmission events between patients of the same clone with the same combination of carbapenemases (KPC-3 + VIM-1-ST29-<em>K. pneumoniae</em>, NDM-1 + OXA-48-ST147-<em>K. pneumoniae</em> and KPC-2 + VIM-1-ST145-<em>K. oxytoca</em>). Carbapenemase-encoding genes were located on different plasmids, except for VIM-1 + KPC-2-ST145-<em>K. oxytoca</em>. Cross-species transmission and a possible acquisition overtime was found, particularly between <em>K. pneumoniae</em> and <em>E. coli</em> producing OXA-48 + KPC-3.</p></div><div><h3>Conclusion</h3><p>M-CPE is an emerging threat in our hospital. Co-production of different carbapenemases, including metallo-β-lactamases, limits therapeutic options and depicts the need to reinforce infection control measures.</p></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213716524001267/pdfft?md5=32317470c5c6ad4db875d5b87dd73b91&pid=1-s2.0-S2213716524001267-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141600242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of global antimicrobial resistance
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1